First local patient receives groundbreaking cancer therapy

If young Ariana Benedé could see all the science that has been built after her name and the lives saved from her commitment, almost a decade ago, to bring to the Hospital Clínic de Barcelona a promising immunotherapy against cancer, “from the outset, she would not believe it,” says the hematologist Álvaro Urbano, coordinator of the CAR-T Program of the Clinic-IDIBAPS.

First local patient receives groundbreaking cancer therapy

ALBANY, N.Y. (NEWS10) -- History is being made in local cancer care. New York Oncology Hematology administered the first commercial CAR T cancer treatment in the region to a man with blood cancer on Tuesday. The breakthrough medical technology uses a patient's immune cells to fight cancer through a one-time IV infusion. Previously, patients had to travel and stay hours away for the treatment, but Tuesday's treatment was administered in Albany, a…

CAR-T cancer treatment available in the Capital Region for the first time

A new kind of cancer treatment is now available in Albany.

CAR T-cell therapy successfully treats myeloma in Hong Kong

A CAR T-cell therapy manufactured in mainland China has been successfully deployed for the first time in Hong Kong to treat a man with myeloma, according to the University of Hong Kong. The 73-year-old man was diagnosed with myeloma in 2010, according to a university news story. Four years after the diagnosis, he received standard frontline myeloma treatment, which involves targeted therapy followed by a stem cell transplant. His myeloma soon re…

CAR T-Cell Pioneer Plots Technology’s Next Steps

Renier Brentjens, a CAR T-cell pioneer, views armored CAR T-cells as a promising avenue for treating solid tumors and predicts that a treatment could be approved in the next 5-10 years. Medscape Medical News